Strata Skin Sciences (SSKN)
(Delayed Data from NSDQ)
$0.51 USD
-0.01 (-2.78%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $0.51 0.00 (-0.87%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SSKN 0.51 -0.01(-2.78%)
Will SSKN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SSKN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SSKN
New Strong Buy Stocks for February 14th
Strata Skin Sciences, Inc. (SSKN) Reports Q3 Loss, Tops Revenue Estimates
SSKN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tabula Rasa Healthcare (TRHC) Reports Q3 Loss, Tops Revenue Estimates
Strata Skin Sciences, Inc. (SSKN) Reports Q2 Loss, Tops Revenue Estimates
Health Catalyst (HCAT) Reports Q2 Loss, Tops Revenue Estimates
Other News for SSKN
STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
Strata Skin Sciences Announces Reverse Stock Split
STRATA Skin Sciences announces 1-for-10 reverse stock split
Strata Skin Sciences announces 1-for-10 reverse stock split
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024